ArticleFrontiers in public health2021

Chinese Medicine Combined With EGFR-TKIs Prolongs Progression-Free Survival and Overall Survival of Non-small Cell Lung Cancer (NSCLC) Patients Harboring EGFR Mutations, Compared With the Use of TKIs Alone.

Yujia Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.